Researchers have been excited about this new drug, a novel dual compound showing remarkable results in early trials for size management. It works by targeting several pathways : GLP-1 and GIP, which , when stimulated, support influence cravings and boost calorie burn. Preliminary reports indicate substantial weight reduction and potential advantage